Apple Watch Series 12 hypertension notifications delayed in India
Apple has delayed the rollout of hypertension notification features for the Watch Series 12 and Ultra 4 in India until next year. The company is currently awaiting necessary regulatory clearances to enable these health-tracking capabilities.
Why it matters
This delay highlights the regulatory hurdles global tech companies face when introducing advanced health-monitoring features in international markets.
Apple has delayed the hypertension notification feature on Watch Series 12 and Ultra 4 in India to next year, pending additional regulatory clearances. The Watch Series 12 will be available from September 18 at a starting price of Rs 56,900.
US technology major Apple has delayed the hypertension notification feature on Watch Series 12 in India to next year pending regulatory clearances, the company said on Wednesday.
Apple has opened pre-order options for customers across several markets including India, with the Watch Series 12 to become available across stores from September 18, at starting price of Rs 56,900 a piece.
“Hypertension notifications will not be initially available in India on Apple Watch Series 12 or Ultra 4, as additional regulatory clearances for the feature for these models is in process. Availability is expected next year,” the company said in a statement.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in